Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Post by Kanatainvestoron Aug 01, 2023 7:37am
104 Views
Post# 35566373

Great Q1 Report

Great Q1 Report- Revenue higher than consensus  (driven by strong SSS at 4.1%)
- Adjusted EBITDA margin higher than consensus at 10.1% (up 30 basis points from last year Q1)
- Adjusted net income higher than expected at 11c (22% higher than last year Q1).
- 16 new graduates joining the neighborly during the third week of August.
- Expanded scope of pharamcy in BC and ON driving positive trends (long term this a critical industry driver).

Looking forward to listening to the CC, but my guess, even without additional insights from the CC, based on the strength of this report,  the stock will be upgraded, and will likely trade above its IPO price shortly. 

<< Previous
Bullboard Posts
Next >>